CHMP recommends Idorsia’s dual acting treatment Quviviq for insomnia patients
Quviviq can be used on a long-term basis, addressing a key limitation of existing therapies
Read More
Author: John Pinching
Neglected rare disease patients offered hope in new plan
Unmet need among over 7000 rare diseases is being addressed in a comprehensive action plan
Read More
CHMP provides initial assessment of Valneva’s COVID-19 vaccine
Valneva expects to receive a positive CHMP recommendation for the conditional approval of its VLA2001 vaccine
Read More
Community pharmacies save 20,000 lives during initial vaccination phases
Figures by National Audit Office estimate that programme prevented up to 262,000 hospitalisations
Read More
Data from first DMT-assisted clinical trial revealed
No sign of significant negative effects on anxiety and wellbeing following pioneering Small Pharma trial
Read More
